How to manage lichen sclerosus after circumcision?

Hello,

Welcome to icliniq.com.

I can understand your concern.

Since you already have biopsy-proven lichen sclerosis, any new or persistent redness at the meatus or inside the fossa navicularis should be taken seriously and checked by a specialist, even if it is subtle and even if it was not clearly visible at your GP (general practitioner) visit.

From the photo (attachment removed to protect patient identity), this appears to be a focal area of redness just inside the urinary opening, with some paler skin surrounding it. In someone with LS (lichen sclerosis), this can represent:

• Active LS-related inflammation involving the meatus or fossa.
• Early scarring changes that can later lead to meatal or urethral narrowing.
• Much less commonly, premalignant change (this is rare at your age, but LS does slightly increase long-term risk, which is why we do not ignore persistent lesions).

Most of the time, this turns out to be inflammatory, but the only safe approach is to have it properly examined. I do think you should pursue further healthcare and see a urologist (or a dermatologist experienced with genital LS). They may:

• Examine the meatus closely with good lighting or magnification.
• Check whether there is any early narrowing of the opening.
• Ask about urinary flow and spraying.
• If there are symptoms or concerns, they may suggest uroflow tests or a flexible cystoscopy.
• If the red area looks suspicious or does not respond to treatment, they may recommend a small biopsy.

Please do not wait if you notice the following symptoms:

• Weak or spraying urine stream.
• Burning at the tip when urinating.
• Recurrent infections.
• Bleeding from the opening.
• An ulcer, sore, or area that seems to be growing.

If you are on maintenance steroid therapy for LS, continue that as prescribed on the external skin. Do not apply strong steroids deep into the urethra unless specifically told to by your specialist. I know this is stressful, but at your age and with this appearance, cancer is unlikely. Still, because LS can involve the urethral opening and can occasionally cause long-term problems if untreated, this is exactly the kind of change that should be reviewed rather than ignored. So, I would advise arranging a urology review.

I hope this information will help you.

Kindly follow up if you have any further concerns.

Thank you.

Hello,

Welcome back to icliniq.com.

I completely understand why this is worrying, especially given your background and the fact that you have already done a deep dive into the literature.

You are absolutely right that male genital LS is not only about white plaques, and redness, erosions, or focal inflammation at the meatus or fossa navicularis can be very relevant findings. LS involving the fossa navicularis and distal urethra is well-described, and redness can reflect:

• Active inflammatory LS.
• Post-inflammatory change.
• Less commonly, dysplastic change.

You have used Clobetasol for a month with no response, which does not automatically mean cancer, but it does mean:

• This may not be simple active LS inflammation alone.
• It could be epithelial irritation, early scarring change, or a different inflammatory process. And yes, persistent steroid-resistant focal lesions in LS do warrant further evaluation.

So, your instinct to pursue a second opinion is absolutely correct.

About SCC (squamous cell carcinoma) risk, you are right that LS carries an increased risk of SCC, but also:

• The absolute risk is still low, especially in men under 40.
• Cancer usually presents as ulceration, induration, bleeding, or a growing lesion, not just stable redness, and a lack of progression over weeks to months strongly argues against malignancy.

So while we should not ignore this, nothing in what you have described screams cancer at this stage. At your second-opinion appointment, I would hope the urologist considers:

• Careful inspection of the meatus and fossa with good lighting or magnification.
• Assessment of urinary stream and any subtle voiding changes by performing a uroflowmetry.
• If the lesion looks grossly abnormal or remains unexplained, the next step is a low-threshold biopsy.

About the stricture risk, your concern here is very appropriate. LS-related strictures usually evolve slowly, and early signs are:

• Spraying.
• Reduced stream.
• Post-void dribbling.
• Burning.

If you are not having these, that is reassuring, but it is still reasonable to keep this on the radar. The uroflowmetry test will help determine if the flow pattern is suggestive of a stricture. Please let me know what the second urologist says, and whether they feel biopsy or urethral evaluation is needed. If you would like, once you have had that visit, you can update me, and I am very happy to help you think through the next steps.

I hope this helps.

Kindly follow up if you have more concerns.

Thank you.

Hello,

Welcome back to icliniq.com.

I read your query and can understand your concern.

Thanks for the detailed update, and the new photo (attachment removed to protect patient's privacy). I understand why this is hard to let go of. From the photo, what you are showing appears like a well-demarcated red patch of urethral mucosa at or just inside the meatus. Some degree of redness of the fossa navicularis or mucosa can be completely normal because this is mucosal tissue (not keratinized skin), and it can look redder depending on light, angle, hydration, friction, and minor irritation.

Importantly, you have now had two urologists examine you in person and review photos, and both felt it was within normal variation, which carries significant weight. If a lesion is unchanged despite a proper high-potency steroid trial, it often suggests one of two things:

1. It is not an actively inflammatory LS at that spot, or
2. It is mucosal irritation or vascularity where a steroid will not turn it white or normal, the way it might on penile skin.

So the lack of response to Clobetasol propionate 0.05 % is not, by itself, a sign of cancer; it can actually support the idea that this is not active LS in that area. If there are no progressive symptoms and the exam is reassuring, tapering is a sensible next step. Because this is near the meatus or fossa, I generally prefer not to keep high-potency steroids indefinitely unless there is clear active disease, while the goal is minimum effective dose. My suggestions for now:

1. Focus on symptom control: barrier care. Use a bland emollient barrier, such as petrolatum, around the meatus (a very small amount), once daily for two to three weeks.
2. Avoid irritants like fragranced soaps, strong cleansers, over-washing, and friction.
3. If itching persists, sometimes a short course of a lower-potency steroid externally (not inside) is safer than repeated Dermovate (Clobetasol propionate).
4. Monitor for urethral involvement by function, not by colour alone.

The key LS complications you are worried about are meatal stenosis or fossa stricture, and (rarely) malignant change. Colour is less important than new spraying, weak stream, prolonged voiding, straining, recurrent UTIs (urinary tract infections), and progressive narrowing of the meatus. If any of these occur, then the next step is objective assessment using uroflow, post-void residual, and, if indicated, urethroscopy. A biopsy is usually considered if there is:

• A persistent ulcer, crusting, and bleeding spot.
• A firm or indurated lesion.
• Rapidly changing appearance.
• Persistent pain (not just mild itch).
• A lesion that looks clinically suspicious on a specialist exam.

Your description or photo, your local urologist’s opinions. Do not strongly point that way right now. Please arrange an earlier review if you notice:

• Worsening urinary stream or spray, or increasing difficulty passing urine.
• Visible ulceration, bleeding, a raised lump, or a non-healing sore.
• Escalating pain, or redness spreading with new white thickening or scarring.

With LS, it is very easy to scan the area repeatedly, and that can amplify both irritation and anxiety. A reasonable, safer approach is to take one standardized photo once every four to six weeks (same lighting or distance) and otherwise avoid repeated inspection. One quick question for you:

Do you have any urinary symptoms at all currently, such as spraying, weak stream, straining, or prolonged voiding?

Regards.

Thank you.

Hi,

Welcome back to icliniq.com.

Thank you for sharing the translated clinic note (attachment removed to protect patient identity) that is actually very helpful. I am glad you took the time to get a second independent opinion. After reading it carefully, I am even more reassured about your situation. What the urologist documented is very reassuring.

I must say, sometimes the transitional zone often looks redder, thinner, and more vascular than the surrounding skin, especially under bright light, magnification, or repeated inspection. Many patients never notice this area simply because they are not examining it daily with a torch and camera. In other words, what you are seeing visually matches very well with what the urologist described as normal mucosal anatomy rather than active disease. Your urinary function strongly argues against dangerous progression; this is extremely important.

If lichen sclerosus were actively progressing into the fossa navicularis in a clinically meaningful way, the earliest signal is almost always urinary change, slowing, spraying, burning, narrowing of stream, post-void dribbling, or recurrent infections. The absence of any of these strongly supports stability. Dermovate (Clobetasol propionate) non-response does not imply malignancy here. If the tissue is normal transitional mucosa, the steroid will understandably do nothing, because there is nothing pathologic to suppress.

A lack of response in this context does not imply cancer or progression. Some advice for you:

1. Continue bland emollient care (petrolatum is fine).
2. Avoid chronic daily ultra-potent steroids on normal mucosa unless there is a clear relapse.
3. Occasional mild itching alone is not alarming.
4. Isolated mild itch without visible progression, ulceration, or urinary symptoms is not concerning.

Two things are important:

• You cannot eliminate uncertainty entirely in chronic disease. The goal is rational surveillance, not zero risk.
• Excessive self-examination amplifies anxiety and visual misinterpretation. Mucosa changes appearance dramatically depending on lighting, hydration, angle, and vascular tone. Your plan to reduce inspection frequency is exactly the right move.

You should re-consult if any of the following appear:

• New ulceration or erosion.
• Persistent bleeding.
• Increasing pain or burning.
• New progressive whitening or thickening.
• Stream weakening, spraying, and narrowing.
• Recurrent UTIs.
• Visible growth or non-healing lesion.

Absent these, observation is appropriate. You are handling this in a very mature, thoughtful way, and you have done all the right things medically. If anything changes in the future, I am always happy to reassess with you.

I hope this information helps you.

Feel free to ask further queries.

Thank you.